Ocean Pharma
Generated 5/24/2026
Executive Summary
Ocean Pharma is a Vadodara-based Indian pharmaceutical company founded in 2014, specializing in the manufacture and marketing of generic formulations across infectious diseases, oncology, and gastroenterology. The company's portfolio includes anti-HIV, anti-cancer, hepatitis, and supportive care medicines, with a focus on high-quality manufacturing, regulatory compliance, and cold-chain logistics. As a commercial-stage private entity, Ocean Pharma serves both domestic and international markets through contract manufacturing and its own branded generics. While the company has established a solid operational foundation, its private status and lack of disclosed financials limit visibility into growth trajectory. Nonetheless, its niche in affordable generics for critical disease areas positions it well in the expanding Indian pharmaceutical sector.
Upcoming Catalysts (preview)
- Q3 2026WHO Prequalification for HIV Generic70% success
- Q2 2026Launch of New Oncology Product in India65% success
- Q4 2026Expansion into African market via partnership60% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)